SCHEMBL3661518

SCHEMBL3661518

CC=CCCCCCOc1cccc(NC)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.35
LTB4R2 Q9NPC1 1/20 0.35
L3MBTL1 Q9Y468 4/20 0.34
SLC6A4 P31645 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
PTPN1 P18031 1/20 0.34
HPGD P15428 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HRH1 P35367 1/20 0.32
PPARG P37231 1/20 0.32
APP P05067 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2C9 P11712 2/20 0.31
TP53 P04637 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3770670 1.00 LTB4R (0.35) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3766276 0.99 LTB4R (0.36) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3664801 0.99 LTB4R (0.36) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3770862 0.94 L3MBTL1 (0.36) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3663647 0.94 L3MBTL1 (0.36) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3659827 0.90 APP (0.33) L3MBTL1SLC6A4TDP1ALDH1A1MAPT
SCHEMBL3764832 0.90 APP (0.33) L3MBTL1SLC6A4TDP1ALDH1A1MAPT
SCHEMBL3661806 0.86 L3MBTL1 (0.37) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3770873 0.86 L3MBTL1 (0.37) LTB4RLTB4R2L3MBTL1SLC6A4TDP1
SCHEMBL3659270 0.85 L3MBTL1 (0.35) L3MBTL1SLC6A4TDP1ALDH1A1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 LTB4R 2885/4885LTB4R2 1911/4885L3MBTL1 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.